TREA

97132237 - K

Follow

Information

  • Trademark
  • 97132237
  • Serial Number
    97132237
  • Filing Date
    November 18, 2021
    3 years ago
  • Transaction Date
    December 13, 2024
    a month ago
  • Status Date
    June 25, 2024
    6 months ago
  • Published for Opposition Date
    May 02, 2023
    a year ago
  • Location Date
    June 27, 2023
    a year ago
  • Status Code
    731
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    CASE, LEIGH
  • Attorney Docket Number
    491396-00014
    Attorney Name
    Fara S. Sunderji
    Law Office Assigned Location Code
    M30
  • Owners
Information
Mark Drawing Code
3
Mark Identification
K
Case File Statements
  • DM0000: The mark consists of a stylized letter K.
  • GS0051: A house mark for a full line of pharmaceuticals; pharmaceuticals for use in the treatment of central nervous system disorders, pain, opioid overdose, opioid reversal, opioid use disorders, interstitial cystitis/bladder pain syndrome (IC/BPS), Overactive Bladder (OAB), Alcohol Use Disorder, Substance Use Disorder, sleep disorders including Insomnia Associated with Alcohol Cessation (IAAC), anaphylaxis; pharmaceuticals for use in the treatment of oncology conditions, specifically glioblastoma multiforme (GBM), non Hodgkin lymphoma, solid tumors, melanoma, chronic myelogenous leukemia, hemato-oncology, refractory/relapsed malignancies, alone or in combination with other agents; analgesics; pharmaceuticals, namely, opioid antagonists; syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; syringes filled with opioid antagonists; injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; injectors filled with opioid antagonists; injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; injectable pharmaceuticals, namely, opioid antagonists
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0421: Pharmaceutical research and development
Case File Event Statements
  • 6/14/2022 - 2 years ago
    6 - PRIORITY ACTION E-MAILED Type: GPRA
  • 11/22/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 11/23/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/24/2021 - 3 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 6/7/2022 - 2 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/14/2022 - 2 years ago
    5 - PRIORITY ACTION WRITTEN Type: CPRA
  • 6/14/2022 - 2 years ago
    7 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN
  • 12/7/2022 - 2 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/7/2022 - 2 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/7/2022 - 2 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/14/2022 - 2 years ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/16/2023 - a year ago
    14 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 3/16/2023 - a year ago
    15 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 3/16/2023 - a year ago
    16 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 3/16/2023 - a year ago
    17 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 3/27/2023 - a year ago
    18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/27/2022 - 2 years ago
    12 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR
  • 3/7/2023 - a year ago
    13 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX
  • 4/12/2023 - a year ago
    19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/2/2023 - a year ago
    20 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/2/2023 - a year ago
    21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 12/19/2023 - a year ago
    23 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 12/19/2023 - a year ago
    24 - SOU EXTENSION 1 FILED Type: EXT1
  • 6/27/2023 - a year ago
    22 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 12/19/2023 - a year ago
    25 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 12/21/2023 - a year ago
    26 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 6/25/2024 - 6 months ago
    27 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 6/25/2024 - 6 months ago
    30 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 6/25/2024 - 6 months ago
    29 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 6/25/2024 - 6 months ago
    28 - SOU EXTENSION 2 FILED Type: EXT2
  • 12/13/2024 - a month ago
    31 - SOU TEAS EXTENSION RECEIVED Type: EEXT